MedTrace Logo

Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis

NCT03176966 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2022-10-31

Study results available
· View outcomes & findings →

Summary

The investigator's aim is to compare the efficacy of Ropinirole (Requip) to vitamin E in the treatment of muscle cramps in cirrhotic patients.

Conditions

  • Muscle Cramp
  • Cirrhosis

Interventions

DRUG

Vitamin E

Patients will take 400 IU vitamin E nightly for 3 months.

DRUG

Ropinirole

Patients will take 0.5mg ropinirole nightly for 3 months.

OTHER

Muscle cramp survey

Patients will complete a survey of muscle cramp frequency and severity at baseline, 3 months, and 6 months.

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Andrew Scanga, MD · Vanderbilt University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-02
Primary Completion
2021-10-22
Completion
2021-10-22
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03176966 on ClinicalTrials.gov